Do you want to read an article? Please log in or register.
Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure
Further Publications
Related content
Further Publications
Patient-Reported Importance of Functional Benefit in Geographic Atrophy
JAMA Ophthalmol
Dinah C, Enoch J, Ghulakhszian A, Sekhon M, Salvatore S, DeSalvo G, Kumar P, Banerjee S, Nayak D, Amoaku W, Shiew M, Osoba O, Crabb DP, Taylor DJ
doi: 10.1001/jamaophthalmol.2025.3264
Further Publications
Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2
JAMA Ophthalmol
von der Emde L, Hou J, Mukherjee S, Vance E, Agrón E, Domalpally A, Keenan TDL, AREDS2 Research Group
doi: 10.1001/jamaophthalmol.2025.3979
RECOMMENDED
Macular DiseasesRetinal Diseases
Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
★ 3
Recommended by
Dr Katarzyna Konieczka, Faculty Member
N Engl J Med
Holz FG, Le Mer Y, Muqit MMK, Hattenbach LO, Cusumano A, Grisanti S, Kodjikian L, Pileri MA, Matonti F, Souied E, Stanzel BV, Szurman P, Weber M, Bartz-Schmidt KU, Eter N, Delyfer MN, Girmens JF, van Overdam KA, Wolf A, Hornig R, Corazzol M, Brodie F, Olmos de Koo L, Palanker D, Sahel JA
doi: 10.1056/NEJMoa2501396
Macular DiseasesRetinal Diseases
Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol
Am J Ophthalmol
Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH
doi: 10.1016/j.ajo.2025.04.022
Macular Diseases
Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial
Prog Retin Eye Res
Dinah C, Esmaeelpour M, Rachitskaya AV, De Salvo G, Munk MR
doi: 10.1016/j.preteyeres.2025.101421
Macular DiseasesRetinal Diseases
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial
Ophthalmology
Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, Kaiser PK, Lally DR, Patel SS, Vajzovic L, Weng CY, Patel H, Clark J, Desai D, Luo D, Henry E, Holz FG, GATHER2 trial investigators
doi: 10.1016/j.ophtha.2025.12.011
Lenses
Association of ocular comorbidities on long-term patient-reported outcome measures after multifocal intraocular lens implantation
Am J Ophthalmol
Tuuminen R, Jeon S
doi: 10.1016/j.ajo.2025.10.001
Macular Diseases
Real-World Experience with Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration
Am J Ophthalmol
Shen M, Berni A, Liu J, Hiya F, Herrera G, El-Mulki OS, Beqiri S, Cheng Y, Kastner J, Trivizki O, Kumar S, Zhang Y, Le VH, O'Brien RC, Nicola MD, Yehoshua Z, Dubovy SR, Wang RK, Gregori G, Rosenfeld PJ
doi: 10.1016/j.ajo.2025.09.006
Macular Diseases
Long-Term Natural History of Treatment-Naïve Geographic Atrophy in Age-Related Macular Degeneration
Transl Vis Sci Technol
Muth DR, Quérat L, Venkataraman AP, Dominguez-Vicent A, Petrovski G, Williams PA, Locri F, Zweifel SA, Kvanta A
doi: 10.1167/tvst.14.5.5